scholarly article | Q13442814 |
P2093 | author name string | Bo Zhang | |
Dan Zhang | |||
Mimi Wang | |||
Linling Wang | |||
Youyou Yan | |||
Nengming Lin | |||
Yangling Li | |||
Jianmei Zeng | |||
P2860 | cites work | The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase-Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells. | Q55032232 |
Cancer statistics, 2013 | Q27860762 | ||
Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
Inhibition mechanism of the intracellular transporter Ca2+-pump from sarco-endoplasmic reticulum by the antitumor agent dimethyl-celecoxib | Q28540515 | ||
α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling | Q34212626 | ||
Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib | Q34445827 | ||
Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer | Q34561552 | ||
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs | Q34743086 | ||
Di(2-ethylhexyl) phthalate-induced apoptosis in rat INS-1 cells is dependent on activation of endoplasmic reticulum stress and suppression of antioxidant protection | Q35206511 | ||
Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737. | Q35531406 | ||
Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia | Q35859229 | ||
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia | Q35958056 | ||
Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer | Q36751571 | ||
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis | Q37742318 | ||
Review article: the epidemiology and prevention of gastric cancer | Q38218870 | ||
2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells | Q38838732 | ||
Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer | Q38843492 | ||
Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E(2) synthase-1 inhibitors | Q38953025 | ||
Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms | Q39062494 | ||
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis | Q39205781 | ||
The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. | Q39273352 | ||
ABT-737 synergizes with arsenic trioxide to induce apoptosis of gastric carcinoma cells in vitro and in vivo | Q39280369 | ||
Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells | Q39360253 | ||
PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells | Q39437267 | ||
Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress | Q39864165 | ||
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib | Q40017297 | ||
Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer | Q42003270 | ||
The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma. | Q42968961 | ||
In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins. | Q43142228 | ||
Antiangiogenic activities of 2,5-dimethyl-celecoxib on the tumor vasculature | Q43144727 | ||
Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model | Q45308080 | ||
Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. | Q51685717 | ||
P433 | issue | 11 | |
P304 | page(s) | 2148-2159 | |
P577 | publication date | 2016-07-04 | |
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | Dimethyl celecoxib sensitizes gastric cancer cells to ABT-737 via AIF nuclear translocation | |
P478 | volume | 20 |
Q47268493 | Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia |
Q64113606 | The Ibr-7 derivative of ibrutinib exhibits enhanced cytotoxicity against non-small cell lung cancer cells via targeting of mTORC1/S6 signaling |
Search more.